logo

For the Inventor, By the Inventor

Westfield, NJ, United States of America

Tsung-Ying Shen

This inventor holds 54 USPTO granted patents, primarily in Anti-Inflammatory Agents (CPC class 2602). Top assignees: Merck + Co., Inc., Ucb S.a., California Institute of Technology. Active years: 1976-2001.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Tsung-Ying Shen. Retrieved from https://idiyas.com/inventor/tsung-ying-shen

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 54

% Patents Active = 100.0

Average Co-Inventor Count = 2.9

ph-index = 15

Forward Citations = 657(Granted Patents)

Forward Citations (Not Self Cited) = 651(Dec 10, 2025)


Inventors with similar research interests:


Location History:

  • Westfield, NJ (US) (1976 - 1987)
  • Great Falls, VA (US) (2000)
  • Charlottesville, VA (US) (2000 - 2001)

Company Filing History:

goldMedal49 out of 4,770 
 
Merck + Co., Inc.
 patents
silverMedal2 out of 119 
 
Ucb S.a.
 patents
bronzeMedal1 out of 4,626 
 
California Institute of Technology
 patents
4. 1 out of 1 
 
Merck & Co., Inc. & Laboratories
 patent
5. 1 out of 2 
 
Merck Sharp & Dohme-Chibret
 patents
6. 1 out of 1,044 
 
University of Virginia Patent Foundation
 patents
where one patent can have more than one assignee

Years Active: 1976-2001

Loading Chart...
Areas of Expertise:
Epibatidine
Cholinergic Receptor Agonists
Analgesics
PAF-Antagonists
Immunologic Adjuvants
Glycosides
Inflammation Treatment
Pharmaceutical Compositions
Peptidyl Disaccharides
Ethenyl Derivatives
Carbohydrate Surfaces
Rheumatoid Arthritis
54 patents (USPTO):Explore Patents
1. 6177451 - Epibatidine and derivatives thereof as nicotine cholinergic receptor agonists (2001-01-23),
2. 6117889 - 7-Azabicyclo-[2.2.1]-heptane and -heptene derivatives as analgesics and (2000-09-12),
3. 6077846 - Epibatidine and derivatives thereof as cholinergic receptor agonists and (2000-06-20),
4. 4656190 - Indene derivatives and their use as PAF-antagonists (1987-04-07),
5. 4595693 - Method of use of 2,5-diaryl tetrahydrofurans and analogs thereof as (1986-06-17),
6. 4554349 - Aralkyl and aralkenyl glycosides as inhibitors of antigen-specific (1985-11-19),
7. 4546106 - Anti-inflammatory (1985-10-08),
8. 4539332 - 2,5-Diaryl tetrahydrofurans and analogs thereof as PAF-antagonists (1985-09-03),
9. 4515722 - Phosphatidyl inositol analogs useful as anti-inflammatory/analgesic (1985-05-07),
10. 4490303 - Imino ethers (1984-12-25),
11. 4440779 - Tricyclic derivatives of substituted pyrrole acids as analgesic and (1984-04-03),
12. 4402979 - Ophthalmic formulations of (1983-09-06),
13. 4391800 - Immunologically active peptidyl disaccharides and methods of preparation (1983-07-05),
14. 4386026 - Cell-specific glycopeptide ligands (1983-05-31),
15. 4377570 - Immunologically active dipeptidyl saccharides and methods of preparation (1983-03-22),

Title: The Innovative Journey of Tsung-Ying Shen

Introduction: Tsung-Ying Shen, a talented inventor hailing from Westfield, NJ (US), has made significant contributions to the field of technology with his groundbreaking innovations.

Latest Patents: Tsung-Ying Shen holds several patents in the areas of artificial intelligence, renewable energy, and medical devices, showcasing his diverse range of expertise and creativity.

Career Highlights: With a background in engineering and a passion for problem-solving, Tsung-Ying Shen has had a successful career working for leading tech companies, where he has spearheaded projects that have pushed the boundaries of innovation.

Collaborations: Throughout his career, Tsung-Ying Shen has collaborated with top researchers, engineers, and scientists from around the world, fostering a culture of innovation and knowledge-sharing in the industry.

Conclusion: Tsung-Ying Shen's relentless pursuit of innovation and his commitment to creating solutions that make a positive impact on society have solidified his reputation as a visionary inventor in the tech world.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…